• Fenoldopam (a medicine that rapidly widens and relaxes blood vessels) probably reduces the risk of developing acute kidney injury (AKI) (a condition where the kidneys suddenly lose their ability to ...
"Arch Biopartners doses first subject in trial of acute kidney injury treatment" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback